Table 1 Background of patients n = 91

Male/Female

58 (64) / 33 (36)

Age

71 (51–86)

Background liver disease

HBV 12 (13)

HCV 42 (46)

ALD 21 (23)

NASH 11 (12)

Others 5 (5)

Serum alubumin (g/dL)

3.7 (2.4–4.4)

Serum total bililubin (mg/dL)

1.3 (0.5–4.7)

Platelet count

4.6 (0.9–6.8)

Number of patients PLT > 50,000

29 (32)

Ascites +/-

73 (80) / 18 (20)

Encephalopathy +/-

84 (92) / 7 (8)

Child Pugh Score / Class

7 (5–11)

A 44 (48)

B 44 (48)

C 3 (3)

ALBI score

-2.18 (-2.99 - -1.17)

mALBI grade

1 19 (21)

2a 23 (25)

2b 45 (50)

3 4 (4)

Performance status 0 / 1

80 (88) / 11 (12)

Spleen Index

> 30　 69 (76)

20 ≦ SI ≦ 30 15 (16)

<20 7 (8)

Tumor size (mm)

17 (8–40)

Number of tumor

1 (1–7)

TNM stage by LCSGJ

I 37 (41)

II 41 (45)

III 12 (13)

IV 1 (1)

BCLC stage

0 15 (17)

A 55 (60)

B 8 (9)

C 11 (12)

D 2 (2)

Interval days*

13 (6–19)